.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Dow
Farmers Insurance
Covington
Mallinckrodt
Medtronic
AstraZeneca
Johnson and Johnson
Chinese Patent Office
Fish and Richardson

Generated: July 25, 2017

DrugPatentWatch Database Preview

HYDROMOX Drug Profile

« Back to Dashboard

What is the patent landscape for Hydromox, and what generic Hydromox alternatives are available?

Hydromox is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in HYDROMOX is quinethazone; reserpine. Additional details are available on the quinethazone; reserpine profile page.

Summary for Tradename: HYDROMOX

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list9
Patent Applications: see list1,267
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDROMOX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
HYDROMOX
quinethazone
TABLET;ORAL013264-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
HYDROMOX R
quinethazone; reserpine
TABLET;ORAL013927-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fuji
Farmers Insurance
Cantor Fitzgerald
Merck
UBS
Dow
Deloitte
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot